Jazz Pharmaceuticals PLC (JAZZ)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | -1.19k | 282.47k | Automatic Disposition | 236.97 | 18.85k | -5.95% |
| 2026-05-28 | Ms. Samantha PearceExec. VP & Chief Commercial Officer | -6.91k | 870.01k | Derivative Exercise and Sale | 109.45 - 235.41 | 17.01k | - |
| 2026-05-28 | Mr. Seamus C. MulliganIndependent Director | 3.42k | 471.54k | Derivative Exercise and Retained Stock | 138.08 | 1.28M | 0.27% |
| 2026-05-22 | Mr. Rick E. WinninghamLead Independent Director | -2.74k | 283.67k | Derivative Exercise and Sale | 138.08 - 241.57 | 6.06k | - |
| 2026-05-22 | Mr. Rick E. WinninghamLead Independent Director | 674.00 | 93.07k | Derivative Exercise and Retained Stock | 138.08 | 6.06k | 12.51% |
| 2026-05-22 | Ms. Heather Ann McSharryIndependent Director | -2.00k | 482.00k | 売り | 241.00 | 14.94k | -11.80% |
| 2026-05-01 | Mr. Bruce C. CozaddCo-Founder & Chairman | -6.00k | 1.22M | 売り | 203.33 | 340.49k | -1.73% |
| 2026-04-01 | Mr. Bruce C. CozaddCo-Founder & Chairman | -6.00k | 1.14M | Automatic Disposition | 190.22 - 191.74 | 346.49k | -1.70% |
| 2026-03-05 | Mr. Bruce C. CozaddCo-Founder & Chairman | -15.11k | 2.85M | Sale to Issuer | 188.69 | 341.89k | -4.23% |
| 2026-03-05 | Mr. Philip L. JohnsonExec. VP & CFO | -2.62k | 493.42k | Sale to Issuer | 188.69 | 20.53k | -11.30% |
| 2026-03-05 | Ms. Mary Elizabeth HendersonSVP of Technical Operations | -1.39k | 260.33k | Sale to Issuer | 186.75 | 7.02k | -16.57% |
| 2026-03-05 | Ms. Samantha PearceExec. VP & Chief Commercial Officer | -2.50k | 472.29k | Sale to Issuer | 188.69 | 17.01k | -12.83% |
| 2026-03-05 | Dr. Robert IannoneExec. VP, Chief Medical Officer and Global Head of Research & Development | -6.21k | 1.17M | Sale to Issuer | 188.69 | 40.33k | -13.34% |
| 2026-03-09 | Ms. Patricia CarrSenior VP & CAO | -1.29k | 235.44k | 売り | 182.94 | 0.00 | -100.00% |
| 2026-03-05 | Ms. Patricia CarrSenior VP & CAO | -1.44k | 268.21k | Sale to Issuer | 186.77 | 0.00 | -100.00% |
| 2026-03-05 | Ms. Renee D. GalaPresident, CEO & Director | -7.07k | 1.33M | Sale to Issuer | 188.69 | 46.93k | -13.08% |
| 2026-03-05 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | -5.00k | 943.45k | Sale to Issuer | 188.69 | 20.04k | -19.96% |
| 2026-03-03 | Mr. Bruce C. CozaddCo-Founder & Chairman | -6.00k | 1.12M | 売り | 186.09 - 187.84 | 324.24k | -1.82% |
| 2026-02-27 | Dr. Norbert G. RiedelIndependent Director | -3.42k | 184.14k | Derivative Exercise and Sale | 138.08 - 192.00 | 14.15k | - |
| 2026-02-27 | Ms. Patricia CarrSenior VP & CAO | -1.12k | 213.24k | 売り | 190.91 | 0.00 | -100.00% |
| 2026-02-26 | Ms. Patricia CarrSenior VP & CAO | -1.25k | 243.22k | 売り | 194.11 | 0.00 | -100.00% |
| 2026-02-26 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | 47.21k | 5.99M | Derivative Exercise and Retained Stock | 113.10 - 137.12 | 14.25k | -143.24% |
| 2026-02-26 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | -3.79k | 222.74k | Derivative Exercise and Sale | 113.10 - 192.07 | 14.25k | - |
| 2026-02-26 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | -51.81k | 9.93M | 売り | 190.00 - 193.60 | 14.25k | -78.43% |
| 2026-02-26 | Ms. Mary Elizabeth HendersonSVP of Technical Operations | -5.34k | 1.04M | 売り | 194.49 | 5.77k | -48.07% |
| 2026-01-16 | Ms. Neena M. PatilExec. VP & Chief Legal Officer | -3.28k | 560.55k | Sale to Issuer | 171.16 | 18.85k | -14.80% |
| 2026-01-16 | Ms. Samantha PearceExec. VP & Chief Commercial Officer | -1.60k | 273.68k | Sale to Issuer | 171.16 | 13.33k | -10.71% |
| 2026-01-16 | Dr. Robert IannoneExec. VP, Chief Medical Officer and Global Head of Research & Development | -4.14k | 708.60k | Sale to Issuer | 171.16 | 31.92k | -11.48% |
| 2026-01-16 | Ms. Renee D. GalaPresident, CEO & Director | -5.37k | 919.30k | Sale to Issuer | 171.16 | 37.11k | -12.64% |
| 2026-01-16 | Mr. Bruce C. CozaddCo-Founder & Chairman | -17.45k | 2.99M | Sale to Issuer | 171.16 | 308.45k | -5.36% |
| 2025-08-18 | Mr. Patrick Gerald EnrightIndependent Director | -5.00k | 0.00 | Other Disposition | - | 17.87k | -21.86% |
| 2025-12-09 | Ms. Mary Elizabeth HendersonSVP of Technical Operations | -2.24k | 379.37k | 売り | 169.51 | 999.00 | -69.14% |
| 2025-12-05 | Ms. Renee D. GalaPresident, CEO & Director | -80.00 | 13.35k | Sale to Issuer | 166.91 | 29.74k | -0.27% |
| 2025-12-05 | Ms. Patricia CarrSenior VP & CAO | -4.50k | 137.39k | Derivative Exercise and Sale | 140.67 - 171.20 | 0.00 | - |
| 2025-12-05 | Ms. Patricia CarrSenior VP & CAO | -160.00 | 27.38k | 売り | 171.11 | 0.00 | -100.00% |
| 2025-12-02 | Mr. Kenneth William O’Keefeインサイダー | -603.00 | 104.36k | Sale to Issuer | 173.07 | 26.75k | -2.20% |
| 2025-11-26 | Mr. Bruce C. CozaddCo-Founder & Chairman | -77.50k | 4.22M | Derivative Exercise and Sale | 123.36 - 179.79 | 289.98k | - |
| 2025-11-20 | Ms. Heather Ann McSharryIndependent Director | -3.42k | 135.58k | Derivative Exercise and Sale | 138.08 - 177.78 | 16.94k | - |
| 2025-11-19 | Ms. Mary Elizabeth HendersonSVP of Technical Operations | -1.33k | 240.11k | Sale to Issuer | 180.40 | 3.24k | -29.14% |
| 2025-11-18 | Mr. Bruce C. CozaddCo-Founder & Chairman | -17.28k | 3.13M | 売り | 180.09 - 181.81 | 289.98k | -5.62% |
| 2025-11-18 | Mr. Bruce C. CozaddCo-Founder & Chairman | -717.00 | 130.92k | 売り | 182.60 | 289.98k | -0.25% |
| 2025-11-18 | Ms. Patricia CarrSenior VP & CAO | -5.25k | 240.92k | Derivative Exercise and Sale | 136.18 - 182.07 | 621.00 | - |
| 2025-11-18 | Ms. Patricia CarrSenior VP & CAO | -69.00 | 12.53k | 売り | 181.66 | 621.00 | -10.00% |
| 2025-11-18 | Mr. Rick E. WinninghamLead Independent Director | -5.50k | 994.73k | 売り | 180.86 | 5.39k | -50.52% |
| 2025-11-17 | Dr. Robert IannoneExec. VP, Chief Medical Officer and Global Head of Research & Development | -7.16k | 1.20M | Automatic Disposition | 168.26 | 24.29k | -22.77% |
| 2025-10-01 | Mr. Bruce C. CozaddCo-Founder & Chairman | -5.50k | 753.56k | Automatic Disposition | 131.78 - 140.00 | 307.98k | -1.75% |
| 2025-09-14 | Mr. Bruce C. CozaddCo-Founder & Chairman | -15.65k | 1.97M | Sale to Issuer | 126.16 | 313.48k | -4.75% |
| 2025-09-02 | Mr. Bruce C. CozaddCo-Founder & Chairman | -6.00k | 771.69k | Automatic Disposition | 127.23 - 130.00 | 329.13k | -1.79% |
| 2025-08-08 | Mr. Kenneth William O’Keefeインサイダー | -1.81k | 200.81k | Sale to Issuer | 111.25 | 29.61k | -5.75% |
| 2025-08-08 | Ms. Jennifer E. CookIndependent Non-Executive Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 7.33k | -19.76% |
| 2025-08-08 | Mr. Patrick Gerald EnrightIndependent Director | -1.81k | 200.80k | Sale to Issuer | 111.25 | 22.87k | -7.31% |
| 2025-08-08 | Ms. Laura Jean HamillIndependent Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 3.43k | -34.51% |
| 2025-08-08 | Mr. Patrick T. KennedyIndependent Director | -1.96k | 217.94k | Sale to Issuer | 111.25 | 3.20k | -38.01% |
| 2025-08-08 | Ms. Heather Ann McSharryIndependent Director | -1.96k | 217.94k | Sale to Issuer | 111.25 | 16.94k | -10.36% |
| 2025-08-08 | Ms. Anne O'RiordanIndependent Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 12.99k | -12.20% |
| 2025-08-08 | Dr. Norbert G. RiedelIndependent Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 14.15k | -11.32% |
| 2025-08-08 | Dr. Mark Douglas SmithIndependent Non-Executive Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 7.33k | -19.76% |
| 2025-08-08 | Mr. Rick E. WinninghamLead Independent Director | -1.81k | 200.81k | Sale to Issuer | 111.25 | 10.89k | -14.22% |
| 2025-08-05 | Ms. Samantha PearceExec. VP & Chief Commercial Officer | -577.00 | 66.99k | Sale to Issuer | 116.10 | 11.16k | -4.92% |
| 2025-08-01 | Mr. Bruce C. CozaddCo-Founder & Chairman | -1,000.00 | 113.21k | Automatic Disposition | 113.21 | 335.13k | -0.30% |
| 2025-07-01 | Mr. Bruce C. CozaddCo-Founder & Chairman | -1,000.00 | 107.63k | Automatic Disposition | 105.26 - 110.00 | 336.13k | -0.30% |
| 2025-06-02 | Mr. Bruce C. CozaddCo-Founder & Chairman | -1,000.00 | 108.95k | Automatic Disposition | 107.90 - 110.00 | 337.13k | -0.30% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。